REVVITY, INC. (RVTY)
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Address
940 WINTER STREET
WALTHAM, MA 02451
Founded
1937
Number of Employees
11,500
Website
http://www.revvity.com
Buyback
Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
$ Amount Purchased ($ in 000s ) |
- | - | - | $1,026 | $52,456 | $112 | $116 | $60 | $24,501 | $4,939 | - | $11,887 |
Average Price | - | - | - | $65.39 | $80.33 | $85.34 | $128.58 | $184.37 | $134.16 | $107.59 | - | $92.48 |
# Shares Purchased | - | - | - | 15,695 | 653,000 | 1,314 | 901 | 323 | 182,619 | 45,905 | - | 128,537 |
Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Return to Date | - | - | - | 86.6% | 51.9% | 43.0% | -5.1% | -33.8% | -9.1% | 13.4% | - | 31.9% |
S&P 500 Return to Date | - | - | - | 129.7% | 104.9% | 93.1% | 74.8% | 31.7% | 37.3% | 31.3% | - | 71.8% |
Excess Total Return | - | - | - | -43.2% | -53.0% | -50.1% | -80.0% | -65.5% | -46.3% | -17.9% | - | -39.9% |
Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
Percentile Rank | - | - | - | 65% | 59% | 56% | 25% | 22% | 37% | 53% | - | 62% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)